What are the responsibilities and job description for the VP Oncology Partnerships Leader position at Jobleads-US?
At Arvinas, we are committed to pioneering therapies created with our revolutionary PROTAC protein degradation platform. We are seeking an exceptional Vice President of Sales Oncology to lead the launch strategy and execution plans for our inaugural commercial launch in oncology.
About Us
We are a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Our proprietary PROTAC Discovery Engine platform enables us to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that selectively and efficiently degrade and remove disease-causing proteins.
Our pipeline includes multiple investigational drugs progressing through clinical development programs, including vepdegestrant for locally advanced or metastatic ER /HER2- breast cancer, ARV-102 for neurodegenerative disorders, and ARV-393 for relapsed/refractory non-Hodgkin Lymphoma. In April 2024, we entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for prostate cancer treatment.
We are driven by our mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. As a key member of our Commercial Leadership Team (CLT), the broader Arvinas Leadership Team (ALF) and Sales Leadership Team (SLT), this leadership position holds significant importance as it spearheads the establishment of our sales capabilities in oncology.
